PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-30.68%
Negative revenue growth while AVGO stands at 4.73%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-37.17%
Negative gross profit growth while AVGO is at 3.89%. Joel Greenblatt would examine cost competitiveness or demand decline.
-69.57%
Negative EBIT growth while AVGO is at 21.85%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-69.57%
Negative operating income growth while AVGO is at 21.85%. Joel Greenblatt would press for urgent turnaround measures.
-53.90%
Negative net income growth while AVGO stands at 18.46%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-54.90%
Negative EPS growth while AVGO is at 16.67%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-53.06%
Negative diluted EPS growth while AVGO is at 17.65%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
-0.96%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
7.69%
Maintaining or increasing dividends while AVGO cut them. John Neff might see a strong edge in shareholder returns.
84.39%
OCF growth above 1.5x AVGO's 2.48%. David Dodd would confirm a clear edge in underlying cash generation.
106.23%
FCF growth above 1.5x AVGO's 3.29%. David Dodd would verify if the firm’s strategic investments yield superior returns.
304.58%
10Y revenue/share CAGR under 50% of AVGO's 702.24%. Michael Burry would suspect a lasting competitive disadvantage.
79.89%
5Y revenue/share CAGR at 50-75% of AVGO's 132.42%. Martin Whitman would worry about a lagging mid-term growth trajectory.
39.30%
3Y revenue/share CAGR similar to AVGO's 40.00%. Walter Schloss would assume both companies experience comparable short-term cycles.
4094.80%
10Y OCF/share CAGR 1.25-1.5x AVGO's 3103.61%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
109.19%
Below 50% of AVGO's 316.29%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
55.53%
3Y OCF/share CAGR at 50-75% of AVGO's 83.82%. Martin Whitman would suspect weaker recent execution or product competitiveness.
438.98%
Below 50% of AVGO's 2497.65%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
260.26%
5Y net income/share CAGR at 75-90% of AVGO's 301.41%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
142.43%
3Y net income/share CAGR 50-75% of AVGO's 234.36%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
244.40%
Below 50% of AVGO's 1327.27%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
95.68%
Below 50% of AVGO's 392.62%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
85.01%
3Y equity/share CAGR above 1.5x AVGO's 32.51%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
89.29%
Below 50% of AVGO's 732.53%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
42.19%
Below 50% of AVGO's 396.08%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-35.83%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
11.15%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.67%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.40%
We have a declining book value while AVGO shows 16.42%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.10%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
6.94%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
3.10%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.